WC
RMD icon

Westerkirk Capital’s ResMed RMD Stock Holding History

Westerkirk Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Hold
2,100
– – 0.04% 162
2026
Q1 		$471K Hold
2,100
– – 0.05% 151
2025
Q4 		$506K Buy
2,100
+600
+40% +$153K 0.05% 152
2025
Q3 		$411K Sell
1,500
-200
-12% -$54.6K 0.05% 205
2025
Q2 		$439K Buy
+1,700
New +$406K 0.05% 195

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Westerkirk Capital's RMD Position: Q2 2026 in Review

Westerkirk Capital held its ResMed (RMD) position steady in Q2 2026 at 2,100 shares worth $409K. The position accounts for 0.04% of the portfolio, ranked #162.

Westerkirk Capital first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $506K in Q4 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Westerkirk Capital held 2,100 shares of ResMed worth $409K as of Q2 2026.
  • Westerkirk Capital left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.04% of Westerkirk Capital's portfolio in Q2 2026, its #162 holding.
  • Westerkirk Capital first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • Westerkirk Capital's ResMed position peaked at $506K in Q4 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Westerkirk Capital's 13F filing for Q2 2026, filed 10 Aug 2026.